Anti-Müllerian hormone is all you need: an assisted reproductive technology perspective in diagnosing polycystic ovary syndrome.
作者信息
McCullough Kate, Ledger William
机构信息
Nepean Clinical School, University of Sydney, Australia.
School of Women's & Children's Health, University of NSW, Australia.
出版信息
Womens Health (Lond). 2016 Jun;12(3):263-5. doi: 10.2217/whe-2016-0005. Epub 2016 May 11.
Abstract
摘要
相似文献
1
Anti-Müllerian hormone is all you need: an assisted reproductive technology perspective in diagnosing polycystic ovary syndrome.抗苗勒管激素就是你所需要的：从辅助生殖技术角度诊断多囊卵巢综合征
Womens Health (Lond). 2016 Jun;12(3):263-5. doi: 10.2217/whe-2016-0005. Epub 2016 May 11.
2
[Anti-Mullerian hormone in the major phenotypes of polycystic ovary syndrome].[抗苗勒管激素在多囊卵巢综合征主要表型中的作用]
Akush Ginekol (Sofiia). 2014;53(5):22-7.
3
Assisted reproductive outcomes in women with different polycystic ovary syndrome phenotypes: the predictive value of anti-Müllerian hormone.不同多囊卵巢综合征表型女性的辅助生殖结局：抗苗勒管激素的预测价值
Reprod Biomed Online. 2016 May;32(5):503-12. doi: 10.1016/j.rbmo.2016.01.010. Epub 2016 Feb 2.
4
[Anti-Müllerian hormone and fertility disturbances in obese women and women with polycystic ovary syndrome].[抗苗勒管激素与肥胖女性及多囊卵巢综合征女性的生育障碍]
Ginekol Pol. 2011 Mar;82(3):205-9.
5
Serum antimüllerian hormone concentrations on day 3 of the in vitro fertilization stimulation cycle are predictive of the fertilization, implantation, and pregnancy in polycystic ovary syndrome patients undergoing assisted reproduction.在体外受精刺激周期的第 3 天，血清抗缪勒管激素浓度可预测多囊卵巢综合征患者接受辅助生殖时的受精、着床和妊娠。
Fertil Steril. 2010 Nov;94(6):2202-7. doi: 10.1016/j.fertnstert.2009.12.002.
6
Increased anti-Mullerian hormone levels and ovarian size in a subgroup of women with functional hypothalamic amenorrhea: further identification of the link between polycystic ovary syndrome and functional hypothalamic amenorrhea.在功能性下丘脑性闭经的亚组妇女中，抗苗勒管激素水平和卵巢大小增加：多囊卵巢综合征和功能性下丘脑性闭经之间联系的进一步鉴定。
Am J Obstet Gynecol. 2016 Jun;214(6):714.e1-6. doi: 10.1016/j.ajog.2015.12.055. Epub 2016 Jan 6.
7
Use of anti-Müllerian hormone testing during ovarian reserve screening to identify women at risk of polycystic ovary syndrome.在卵巢储备功能筛查期间使用抗苗勒管激素检测以识别多囊卵巢综合征风险女性。
Int J Gynaecol Obstet. 2016 Oct;135(1):73-6. doi: 10.1016/j.ijgo.2016.03.026. Epub 2016 Jun 16.
8
Biomarkers of ovarian reserve in women with polycystic ovary syndrome.多囊卵巢综合征患者的卵巢储备标志物。
Semin Reprod Med. 2013 Nov;31(6):452-61. doi: 10.1055/s-0033-1356481. Epub 2013 Oct 7.
9
The prevalence of polycystic ovary syndrome in a normal population according to the Rotterdam criteria versus revised criteria including anti-Mullerian hormone.根据鹿特丹标准与包括抗苗勒管激素在内的修订标准，正常人群中多囊卵巢综合征的患病率。
Hum Reprod. 2014 Apr;29(4):791-801. doi: 10.1093/humrep/det469. Epub 2014 Jan 16.
10
Measurement of anti-Mullerian hormone: performances of a new ultrasensitive immunoassay.抗苗勒管激素的测定：一种新型超灵敏免疫测定法的性能
Clin Biochem. 2015 Apr;48(6):453-5. doi: 10.1016/j.clinbiochem.2014.12.023. Epub 2015 Jan 6.
本文引用的文献
1
AMH MEASUREMENT VERSUS OVARIAN ULTRASOUND IN THE DIAGNOSIS OF POLYCYSTIC OVARY SYNDROME IN DIFFERENT PHENOTYPES.不同表型多囊卵巢综合征诊断中抗苗勒管激素测定与卵巢超声检查的对比
Endocr Pract. 2016 Mar;22(3):287-93. doi: 10.4158/EP15903.OR. Epub 2015 Nov 2.
2
Two new automated, compared with two enzyme-linked immunosorbent, antimüllerian hormone assays.两种新的自动化抗缪勒管激素检测方法，与两种酶联免疫吸附试验相比。
Fertil Steril. 2015 Oct;104(4):1016-1021.e6. doi: 10.1016/j.fertnstert.2015.06.024. Epub 2015 Jul 14.
3
A comprehensive approach in diagnosing the polycystic ovary syndrome.一种诊断多囊卵巢综合征的综合方法。
Womens Health (Lond). 2015 Jul;11(4):501-12. doi: 10.2217/whe.15.13. Epub 2015 Mar 10.
4
Ovarian hyperstimulation syndrome on the acute medical unit: a problem-based review.急性内科病房中的卵巢过度刺激综合征：基于问题的综述
Acute Med. 2015;14(1):21-7.
5
Avoiding ovarian hyperstimulation syndrome with the use of gonadotropin-releasing hormone agonist trigger.使用促性腺激素释放激素激动剂扳机来避免卵巢过度刺激综合征。
Fertil Steril. 2015 Apr;103(4):870-3. doi: 10.1016/j.fertnstert.2015.02.004. Epub 2015 Feb 24.
6
Prospective study into the value of the automated Elecsys antimüllerian hormone assay for the assessment of the ovarian growing follicle pool.前瞻性研究 Elecsys 抗缪勒管激素检测在评估卵巢生长卵泡池中的价值。
Fertil Steril. 2015 Apr;103(4):1074-1080.e4. doi: 10.1016/j.fertnstert.2015.01.004. Epub 2015 Feb 11.
7
Comparison of antimüllerian hormone levels and antral follicle count as predictor of ovarian response to controlled ovarian stimulation in good-prognosis patients at individual fertility clinics in two multicenter trials.在两项多中心试验中，比较个体生育中心的良好预后患者控制性卵巢刺激反应中抗苗勒管激素水平和窦卵泡计数的预测价值。
Fertil Steril. 2015 Apr;103(4):923-930.e1. doi: 10.1016/j.fertnstert.2014.12.114. Epub 2015 Jan 24.
8
Revised criteria for PCOS in WHO Group II anovulatory infertility - a revival of hypothalamic amenorrhoea?世界卫生组织II型无排卵性不孕症中多囊卵巢综合征的修订标准——下丘脑性闭经的复苏？
Clin Endocrinol (Oxf). 2015 Apr;82(4):584-91. doi: 10.1111/cen.12621. Epub 2014 Nov 5.
9
GnRH agonist triggers and their use in assisted reproductive technology: the past, the present and the future.促性腺激素释放激素激动剂触发因素及其在辅助生殖技术中的应用：过去、现在与未来。
Womens Health (Lond). 2014 May;10(3):267-76. doi: 10.2217/whe.14.14.
10
Characterization of women with elevated antimüllerian hormone levels (AMH): correlation of AMH with polycystic ovarian syndrome phenotypes and assisted reproductive technology outcomes.抗苗勒管激素水平（AMH）升高的女性特征：AMH与多囊卵巢综合征表型及辅助生殖技术结局的相关性
Am J Obstet Gynecol. 2014 Jul;211(1):59.e1-8. doi: 10.1016/j.ajog.2014.02.026. Epub 2014 Mar 2.
Zotero 插件